Atlas Trials

Minimally-Invasive Cardiovascular Hemodynamic Optimization (MiCHO) Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock

Clinical trial NCT00535821 · TERMINATED

Trial details

NCT number
NCT00535821
Sponsor
Loma Linda University
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Severe SepsisSeptic Shock
Start date
2007-06-01
Primary completion
2010-09-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.